Abstract
Appetite suppressants, including aminorex and fenfluramine, have been associated with pulmonary hypertension ever since the well-known outbreak of primary pulmonary hypertension in Europe after treatment with aminorex. The usage of a new anorectic agent, dexfenfluramine, has recently increased dramatically in developed countries. We report 2 new cases of lethal pulmonary hypertension associated with the use of dexfenfluramine.
This is a preview of subscription content, log in via an institution to check access.
References
Fraser RG, Paré JAP, Paré PD, Fraser RS, Genereux GP (1990) Primary pulmonary hypertension. In: Manke D (ed) Diagnosis of diseases of the chest. 3rd edn. Saunders, Philadelphia, pp 1842–1848
Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK (1987) Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107: 216–223
Gurtner HP (1990) Aminorex pulmonary hypertension. In: Fishman AP (ed) Pulmonary circulation. University of Pennsylvannia Press, Philadelphia, pp 397–411
Douglas JG, Munro JF, Kitchin AH, Muir AL, Proudfoot AT (1981) Pulmonary hypertension and fenfluramine. Br Med J 283: 881–882
Mc Murray J, Bloomfield P, Miller HC (1986) Irreversible pulmonary hypertension after treatment with fenfluramine. Br Med J 292: 239–240
Editorial (1991) Dexfenfluramine. Lancet 337: 1315–1316
Atanassoff PG, Weiss BK, Schmid ER, Tornic M (1992) Pulmonary hypertension and dexfenfluramine. Lancet 339: 436–437
Roche N, Labrune S, Braun JM, Huchon GJ (1992) Pulmonary hypertension and dexfenfluramine. Lancet 339: 436–437
Brenot F, Hervé P, Petitprez P, Parent F, Duroux P, Simonneau G (1993) Primary pulmonary hypertension and fenfluramine use. Br Heart J 70: 537–541
Pinder RM, Brogden RN, Sauryer PR, Speight TM, Avery GS (1975) Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 10: 241–323
Mc Goon MD, Vanhoutte PM (1984) Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine. J Clin Invest 74: 828–833
Boe J, Simonsson BG, Stahl E (1980) Effect of histamine, 5-hydroxytryptamine, and prostaglandins on isolated pulmonary arteries. Eur J Respir Dis 61: 12–19
Nemecek GM, Coughlin SR, Handley DA, Moskowitz MA (1986) Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci USA 83: 674–678
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cacoub, P., Piette, J.C., Godeau, P. et al. Pulmonary hypertension and dexfenfluramine. Eur J Clin Pharmacol 48, 81–83 (1995). https://doi.org/10.1007/BF00202179
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00202179